Esophageal Atresia Clinical Trials

Find Esophageal Atresia Clinical Trials Near You

Physiopathology of Dumping Syndrome in Esophageal Atresia

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device, Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection difficult to diagnose, because it only occurs after meals and can be inconstantly present. To date, their is only symptomatic treatment for DS. This study aims to understand its pathological mechanisms so as to better treat it and avoid its consequences. Oesophageal atresia patients enrolled in this study will benefit from a continuous glycemic monitoring, a continuous cardiac monitoring, and an a gastric emptying scintigraphy at the age of 3 months

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2 months
Maximum Age: 3 months
Healthy Volunteers: f
View:

• Patients operated at birth for Oesophageal atresia type C

• Aged from 2 to 3 months at inclusion

• Off prokinetic treatment (suspended for at least 72 hours) before monitoring

Locations
Other Locations
France
Hôpital Jeanne de Flandre - Pôle enfant, CHU de Lille
RECRUITING
Lille
Hôpital Jeanne de Flandres
NOT_YET_RECRUITING
Lille
Contact Information
Primary
Madelaine AUMAR, MD
madeleine.aumar@chru-lille.fr
0320445962
Time Frame
Start Date: 2024-02-23
Estimated Completion Date: 2026-11
Participants
Target number of participants: 15
Treatments
Experimental: Experimental group
All children born at the Lille University Hospital during the investigation period with esophageal atresia type III or IV
Related Therapeutic Areas
Sponsors
Collaborators: Groupement Interrégional de Recherche Clinique et d'Innovation, french patient association for oesophageal atresia AFAO
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov